국가: 오스트레일리아
언어: 영어
출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)
SODIUM SALICYLATE
CEVA ANIMAL HEALTH PTY LTD
sodium salicylate(250mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
SODIUM SALICYLATE PHENOL Active 250.0 mg/ml
100mL
VM - Veterinary Medicine
CEVA ANIMAL HEALTH
DOG | HORSE | BITCH | CASTRATE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT
MUSCULOSKELETAL SYSTEM
ANTI-INFLAMMATORY AGENT | ANTIPYRETIC | BONE SORENESS | BRUISING | BURSITIS | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE SORENESS | OSTEOARTHRITIS | PLATELET ACTIVITY | RHEUMATISM | SPRAINS | STRAINS | TENDON SPRAINS | TRAUMATIC SWELLING
Poison schedule: 4; Withholding period: MEAT(Horses): 28 days.; Host/pest details: DOG: [ANTI-INFLAMMATORY AGENT]; HORSE: [ANTI-INFLAMMATORY AGENT]; Poison schedule: 4; Withholding period: WHP: MEAT(Horses): 28 days.; Host/pest details: DOG: [ANTI-INFLAMMATORY AGENT]; HORSE: [ANTI-INFLAMMATORY AGENT]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [ANTI-INFLAMMATORY AGENT]; HORSE: [ANTI-INFLAMMATORY AGENT]; Anti-inflammatory anti-pyretic, anti-thrombotic therapy for horses and dogs.
Registered
2023-07-01
Product Name: APVMA Approval No: NV SALSPRIN INJECTION 51161 / 127372 Label Name: NV SALSPRIN INJECTION Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY READ SAFETY DIRECTIONS BEFORE OPENING OR USING Constituent Statements: 250 mg/mL SODIUM SALICYLATE Claims: Anti-inflammatory, anti-pyretic, anti-thrombotic therapy for horses and dogs. [extended claim] General – For the suppression of mild inflammation and/or fever. (a) MUSCULOSKELETAL Short term treatment of mild joint and connective tissue disease, osteoarthritis, tendon and ligament sprains and exertional myopathy. (b) PYRESIS Symptomatic suppression of fever in situations where the pyresis is inappropriate or excessive. (c) THROMBOSIS Prevention or reduction of thrombosis where it plays a part in disease aetiology. Horse: pedal thrombotic conditions, early disseminated intravascular coagulation. Dog: adjunct to D. immitis adulticide therapy, early disseminated intravascular coagulation. Net Contents: 100 mL Directions for Use: Restraints: DO NOT USE in food-producing animals. RLP APPROVED Contraindications: This product should not be used: -concurrently with aminoglycoside antibiotics. -in animals under 30 days of age. -at anti-inflammatory doses for prolonged periods. -where intestinal ulceration is suspected or has been diagnosed. -in animals with severe renal or hepatic disease, or severe dehydration. Precautions: Side Effects: Dosage and Administration: Use the contents within 3 months of first broaching of the vial. Discard the unused portion. Administer by slow intra-venous injection. Avoid extravasation as irritation and phlebitis may result. Anti-inflammatory: Dog - 10 mg/kg every 12 hours Horse - 35 - 45 mg/kg every 8 - 12 hours Anti-thrombotic: Dog - 3 mg/kg every 6 days Horse - 5 mg/kg every 2nd day or 20 mg/kg every 5th day General Directions: If used in performance animals, the regulations of the relevant authorities regarding medication should be observed. DESCRIPTION: Salsprin is a sterile aq 전체 문서 읽기
SALSPRIN Injection Creation Date: 12 Feb 2007 Revision Date: Sep 2011 Version: 2 Next revision due: Sep 2016 MATERIAL SAFETY DATA SHEET _SALSPRIN INJECTION_ Page 1 of 8 COMPANY DETAILS COMPANY: ADDRESS: Ceva Animal Health Pty Ltd 11 Moores Road ABN 54 002 692 426 Glenorie NSW 2157 Australia TELEPHONE NUMBER: FACSIMILE NUMBER: +61 (02) 9652 7000 +61 (02) 9652 7001 EMERGENCY TELEPHONE NUMBER: +61 (02) 9652 7000 (Business Hours) Poisons Information Centre: 131126 SUBSTANCE IDENTIFICATION PRODUCT NAME: _NV Salsprin Injection_ OTHER NAMES: _Salsprin _ CHEMICAL NAME OF ACTIVE CONSTITUENT, SODIUM SALICYLATE: Sodium 2-hydroxybenzoate MANUFACTURER’S PRODUCT CODE: UN NUMBER: None allocated DANGEROUS GOODS CLASS AND SUBSIDIARY RISK: None allocated HAZCHEM CODE: None allocated SUSDP POISONS SCHEDULE NUMBER: S4 USE: Injectable antiinflammatory, antipyretic and antithrombotic for use in horses and dogs. For animal treatment only. SECTION 1 – IDENTIFICATION OF MATERIAL AND SUPPLIER SALSPRIN Injection Creation Date: 12 Feb 2007 Revision Date: Sep 2011 Version: 2 Next revision due: Sep 2016 MATERIAL SAFETY DATA SHEET _SALSPRIN INJECTION_ Page 2 of 8 STATEMENT OF HAZARDOUS NATURE: Hazardous according to criteria of NOHSC Australia. RISK PHRASES: None. SAFETY PHRASES: None. The substance is a complex mixture, including the following ingredients. INGREDIENTS: CHEMICAL NAME CAS NUMBER PROPORTION Sodium Salicylate 54-21-7 25% (25 mg/mL) Sodium Metabisulfite 7681-57-4 less than 10% Benzyl Alcohol 100-51-6 less than 10% Ingredients determined not to be hazardous to 100% 전체 문서 읽기